131 related articles for article (PubMed ID: 17630191)
1. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.
Nizri E; Irony-Tur-Sinai M; Lavon I; Meshulam H; Amitai G; Brenner T
Int Immunopharmacol; 2007 Sep; 7(9):1129-39. PubMed ID: 17630191
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments.
Nizri E; Adani R; Meshulam H; Amitai G; Brenner T
Neurosci Lett; 2005 Mar; 376(1):46-50. PubMed ID: 15694272
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning.
Amitai G; Adani R; Fishbein E; Meshulam H; Laish I; Dachir S
J Appl Toxicol; 2006; 26(1):81-7. PubMed ID: 16167317
[TBL] [Abstract][Full Text] [Related]
4. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
6. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
7. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
9. Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.
Desplat-Jégo S; Creidy R; Varriale S; Allaire N; Luo Y; Bernard D; Hahm K; Burkly L; Boucraut J
Clin Immunol; 2005 Oct; 117(1):15-23. PubMed ID: 16027043
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Fissolo N; Kraus M; Reich M; Ayturan M; Overkleeft H; Driessen C; Weissert R
Eur J Immunol; 2008 Sep; 38(9):2401-11. PubMed ID: 18792018
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
[TBL] [Abstract][Full Text] [Related]
14. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.
Iruretagoyena MI; Tobar JA; González PA; Sepúlveda SE; Figueroa CA; Burgos RA; Hancke JL; Kalergis AM
J Pharmacol Exp Ther; 2005 Jan; 312(1):366-72. PubMed ID: 15331658
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3.
Irony-Tur-Sinai M; Grigoriadis N; Tsiantoulas D; Touloumi O; Abramsky O; Brenner T
J Neurol Sci; 2009 Apr; 279(1-2):80-7. PubMed ID: 19171355
[TBL] [Abstract][Full Text] [Related]
19. Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES.
Jia Y; Li H; Chen W; Li M; Lv M; Feng P; Hu H; Zhang L
Gene Ther; 2006 Sep; 13(18):1351-9. PubMed ID: 16708076
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
